Company Filing History:
Years Active: 2025
Title: Chenbo Wang - Innovator in DNA Polymerase Theta Inhibition
Introduction
Chenbo Wang is an inventor based in South San Francisco, CA (US). He currently works at Ideaya Biosciences, Inc. His research focuses on developing innovative compounds that target DNA Polymerase Theta, a critical enzyme in cancer biology. Although he has not yet been granted any patents, his work is paving the way for potential breakthroughs in cancer treatment.
Latest Patent Applications
Chenbo Wang has submitted several notable patent applications, including:
1. **SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS** - This application discloses certain thiadiazolyl derivatives that inhibit DNA Polymerase Theta (Polθ) activity. The compounds aim to inhibit Polθ activity by targeting its ATP-dependent helicase domain. Additionally, the application outlines pharmaceutical compositions that include these compounds and methods for treating diseases, particularly cancers that are treatable by Polθ inhibition.
2. **O-LINKED THIADIAZOLYL COMPOUNDS AS DNA POLYMERASE THETA INHIBITORS** - Similar to the previous application, this one also focuses on thiadiazolyl derivatives that inhibit Polθ activity. It emphasizes the potential for these compounds to be used in pharmaceutical compositions and methods for treating cancers, especially those deficient in homologous recombination.
Conclusion
Chenbo Wang is making significant contributions to the field of cancer research through his innovative approaches to inhibiting DNA Polymerase Theta. His latest patent applications reflect a commitment to developing effective treatments for challenging cancers.